19th Annual Peptide Therapeutics Symposium
October 22 – 23, 2024
Scripps Seaside Forum, La Jolla, CA
8610 Kennel Way, La Jolla, CA 92037 |
| Tuesday, October 22, 2024 |
| 8:00 am - 4:00 pm | Registration Check-in
The Scripps Seaside Forum Lobby |
| 8:00 am - 8:30 am | Breakfast & Poster Viewing
The Scripps Seaside Forum Lobby |
| 8:30 am - 5:00 pm | 19th Annual Peptide Therapeutics Symposium
Samuel H. Scripps Auditorium |
| 8:30 am - 8:35 pm | Opening Remarks
Adam Mezo, Ph.D.
President, Peptide Therapeutics Foundation
Vice President, Research, Peptide Chemistry
Neurocrine Biosciences, Inc |
| 8:35 am - 10:05 am | Plenary Lectures
Moderator:
Nick Cox, Ph.D.
Director, Peptide Therapeutics Foundation
Senior Director, Chemical Biology, Novo Nordisk |
| 8:35 am - 9:20 am | Discovery of Amycretin: A GLP-1/amylin Co-agonist for Oral Administration
Thomas Kruse, PhD
Senior Principal Scientist, Novo Nordisk, Denmark |
| 9:20 am - 10:05 am | NMR- and Structure-based Design of Novel Reversible and Covalent Therapeutic Peptides
Maurizio Pellecchia, Ph.D.
Professor of Biomedical Sciences, School of Medicine, University of California Riverside |
| 10:05 am - 10:35 am | Beverage Break & Poster Viewing
The Scripps Seaside Forum Lobby |
| 10:35 am - 12:05 pm | Session I
Moderator:
David Parkes, Ph.D.
President, DGP Scientific, Inc. |
| 10:35 am - 11:05 am | The Discovery of Petrelintide, a Potent, Stable, Long-acting Human Amylin Analog
Henrik Fischer Munch, Ph.D.
Principal Scientist, Department of Medicinal Chemistry, Zealand Pharma, Copenhagen |
| 11:05 am - 11:35 am | Developing Small Molecule Agonists of GLP-1R and other Peptide-Binding GPCRs
Yingli Ma, Ph.D.
Chief Technology Officer, Structure Therapeutics |
| 11:35 am - 12:05 pm | Preserving Skeletal Muscle Mass and Enhancing Fat Loss by Targeting Activin Type II Receptors in Obesity
Paul M. Titchenell, Ph.D.
Associate Professor of Physiology, Perelman School of Medicine at the University of Pennsylvania |
| 12:05 pm - 1:30 pm | Lunch & Poster Viewing
The Scripps Seaside Forum Lawn |
| 1:30 pm - 3:00 pm | Session II
Moderator:
Ron He, Ph.D.
Senior Principal Scientist, Neurocrine Biosciences, Inc. |
| 1:30 pm - 2:00 pm | Advancing Peptide Optimization: Machine Learning-Driven Predictions for Potency, Stability, and Permeability
Ewa Lis, Ph.D.
Founder and CEO, Koliber Biosciences Inc. |
| 2:00 pm - 2:30 pm | Structure Prediction of Cyclic Peptides Via Molecular Dynamics and Machine Learning
Yu-Shan Lin, Ph.D.
Professor, Tufts University |
| 2:30 pm - 3:00 pm | Empowering Peptide Self-Administration with Needle Free Smart Capsules
Sharat Singh, Ph.D.
Head of Research, Biora Therapeutics |
| 3:00 pm– 3:30 pm | Beverage Break & Poster Viewing
The Scripps Seaside Forum Lobby |
| 3:30 pm - 5:00 pm | Session III
Moderator:
Bryan Fuchs, Ph.D.
Head, Ferring Ventures San Diego |
| 3:30 pm - 4:00 pm | Development of Radiopharmaceutical Therapy Agents for Treatment of GPC3-Expressing Tumors
Steven Horton, Ph.D.
Oncology Scientist, RayzeBio |
| 4:00 pm - 4:30 pm | Development and Applications of 68Ga-CBP8, a Type-I Collagen Targeted Peptide-based Positron Emission Tomography Probe
Peter Caravan, Ph.D.
Professor of Radiology, Harvard Medical School
Co-Director of the Institute for Innovation in Imaging, Massachusetts General Hospital |
| 4:30 pm - 5:00 pm | Building on Natural Product Motifs for Cyclic Peptide Inhibitor Discovery
Albert Bowers, Ph.D.
UNC Eshelman School of Pharmacy |
| 5:00 pm - 6:30 pm | Opening Reception
The Scripps Seaside Forum Lawn |
| Wednesday, October 23, 2024 |
| 8:00 am - 10:00 am | Registration Check-in
The Scripps Seaside Forum Lobby |
| 8:00 am - 8:30 am | Breakfast & Poster Viewing
The Scripps Seaside Forum Lobby |
| 8:30 am - 12:45 pm | 19th Annual Peptide Therapeutics Symposium
Samuel H. Scripps Auditorium |
| 8:30 am - 8:45 am | Welcoming Remarks
Nick Cox, Ph.D.
Director, Peptide Therapeutics Foundation
Senior Director, Chemical Biology, Novo Nordisk |
| 8:45 am - 10:15 am | Plenary Lectures
Moderator:
Soumitra Ghosh, Ph.D.
President, Doon Associates LLC |
| 8:45 am - 9:30 am | Identification of Hormonal and Neural Circuits Involved in Gut-Brain Signaling
Nancy A. Thornberry
Founding CEO, Kallyope |
| 9:30 am - 10:15 am | Parathyroid Hormone Peptide Development for Diseases of Bone and Calcium Metabolism
Thomas J Gardella, Ph.D.
Associate Professor in Medicine, Massachusetts General Hospital and Harvard Medical School |
| 10:15 am - 10:45 am | Beverage Break & Poster Viewing
The Scripps Seaside Forum Lobby |
| 10:45 am - 11:45 pm | Session IV
Moderator:
Antoine Henninot
Senior Director, Drug Discovery, Curie.Bio |
| 10:45 am - 11:15 am | Revealing the Role of Neuropeptides in Neural Circuit Function and Behavior
Sung Han, Ph.D.
Associate Professor, Salk Institute for Biological Studies |
| 11:15 am - 11:45 am | RNAi Delivery to the Central Nervous System
Christine Esau, Ph.D.
Vice President, Arrowhead Pharmaceuticals |
| 11:45 am - 12:30 pm | Investor Panel
Moderator:
Rumit Maini
Sr. Director, Peptide Discovery,Eli Lilly
Sarah Benson-Konforty, MD
General Partner at 1010VC
Board Member at AAIH and Pepticom
Mira Chaurushiya, Ph.D.
Senior Partner, Westlake Village BioPartners
Antoine Henninot
Senior Director, Drug Discovery, Curie.Bio
Sally Wang Liang, JD MPH
Partner, Highlight Capital |
| 12:30 pm - 12:45 pm | Closing Remarks
Phil Dawson, Ph.D.
Chairman of the Board, Peptide Therapeutics Foundation
Professor of Chemistry, Scripps Research
|
| 12:45 pm - 1:45 pm | Networking Lunch
The Scripps Seaside Forum Lawn |
